Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Advanced Solid Tumor or Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01345357
What this trial is testing

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Who this might be right for
Solid Tumors or Mantle Cell Lymphoma
Cephalon 24
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Early research (Phase 1)Study completedNCT03311412
What this trial is testing

Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas

Who this might be right for
Metastatic CancerSolid TumorLymphoma
Symphogen A/S 89
Early research (Phase 1)Ended earlyNCT04281420
What this trial is testing

Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid Tumor, Non-Hodgkin's Lymphoma
Antengene Therapeutics Limited 20
Early research (Phase 1)Study completedNCT00364676
What this trial is testing

Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
TumorsHodgkins DiseaseNon-Hodgkins Lymphoma
Spectrum Pharmaceuticals, Inc 67
Early research (Phase 1)Study completedNCT00522652
What this trial is testing

Phase I Trial of PX-478

Who this might be right for
Advanced Solid TumorsLymphoma
Cascadian Therapeutics Inc. 45
Early research (Phase 1)UnknownNCT05650580
What this trial is testing

TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors

Who this might be right for
Non-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma RefractoryAdvanced Solid Tumor
Tarapeutics Science Inc. 26
Early research (Phase 1)Ended earlyNCT02702492
What this trial is testing

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

Who this might be right for
Solid TumorsNHL
Karyopharm Therapeutics Inc 60
Early research (Phase 1)Study completedNCT02018874
What this trial is testing

A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine

Who this might be right for
Solid Tumors and Non-Hodgkin's Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 52
Early research (Phase 1)UnknownNCT00324597
What this trial is testing

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+1 more
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT05384626
What this trial is testing

Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 840
Early research (Phase 1)Study completedNCT01512758
What this trial is testing

Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphomas
Millennium Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT00049699
What this trial is testing

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Early research (Phase 1)Not Yet RecruitingNCT05788107
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma

Who this might be right for
Solid Tumor, Adult Lymphoma
Shanghai Henlius Biotech 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565417
What this trial is testing

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaTriple Negative Breast Cancer+9 more
Immunitas Therapeutics 67
Early research (Phase 1)Study completedNCT03027284
What this trial is testing

Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic CancerBiliary Tract Carcinoma+4 more
Eli Lilly and Company 19
Testing effectiveness (Phase 2)Study completedNCT01177397
What this trial is testing

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more
Celgene 226
Early research (Phase 1)Study completedNCT00978523
What this trial is testing

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Solid TumorsLymphoma
Arno Therapeutics 35
Early research (Phase 1)Ended earlyNCT01185548
What this trial is testing

A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma

Who this might be right for
LymphomaAdvanced Cancer
Eli Lilly and Company 4
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Next Page